Team:Bielefeld-CeBiTec/Results/Biosafety

From 2014.igem.org

Revision as of 04:53, 15 October 2014 by Tore (Talk | contribs)


Biosafety

An important aspect of Synthetic Biology is to prevent the uncontrolled interaction between the genetically modified organismen and the environment and mankind. For this approach there are a lot of ideas in discussion to implement different Biosafety-Systems (Wright et al., 2013) in synthetic Biology to prevent this interaction on one hand. On the other hand there are several studies dealing with the interaction of genetically modified bacteria and natural wild types, demonstrating in most cases that genetically modified bacteria does not influence the environment. Because the genetically modified bacteria are adapted to the excellent conditions of the laboratory, the natural bacteria will usually outlast these modified strains in nature due to their better adaptation to their environment. But there is always a risk remaining and no guarantee that there is really no interaction and that their release does not affect the equilibrium of the environment (Myhr et al., 1999).
So the most problematic factor in this case is the transfer of synthetic or genetically modified DNA, particularly the transfer of antibiotic-resistance, because a genetic exchange of the antibiotic-resistance is an active intervention in the environment.
Therefore we want to establish an antibiotic-free selection system, which opens the possibility of using genetically organism with a reduced remaining risk to the environment, due to the antibiotic-free selection. This antibiotic-free selection system can be used for molecular cloning as well as long-term plasmid stability and on top it turned out, that it is even more efficient than the selection using the antibiotic chloramphenicol...
Antibiotic-free Selection - Introduction

The cell wall is essential for every living bacteria as it confers stability and structure, protects against osmotic pressure and regulates the transport of molecules. The composition of the cell wall differs between bacteria, a feature commonly used in taxonomy. The most common division is based on the Gram-staining into Gram-negative, for example Escherichia coli and Gram-positive Bacteria for example Bacillus subtillis. Gram-negative bacteria are characterized by an inner plasma membrane, a thin peptidoglycan layer, periplasmatic spaces and the outer membrane (see Figure 1). In contrast Gram-positive bacteria generally lack the outer membrane but have a thicker peptidoglycan layer.
Hence, the peptidoglycan layer is an interesting approach to control bacterial cell dvision. Peptidoglycan itself is a polymer consisting of a linear chain of polysaccharides and short peptides. The polysaccharides component are of alternating residues of beta-(1,4) linked N-acetylglucosamine and N-acetylmuramic acid and they are cross-linked in E. coli by a tetra-peptide of L-alanine, D-glutamic acid, meso-diaminopimelic acid and finally D-alanine. The cross-linkage is thereby realized by a transpeptide-linkage of meso-diaminopimelic acid and D-alanine (Cava et al., 2011).

Bild
Figure 1: Structure of the bacterial cell wall of a Gram-negative bacteria. The peptidoglycane layer consist of altering N-acetylglucosamine and N-acetylmuramic acid, which are crosslinked by a tetra-peptide. The crosslinkage is realized with D-alanine and therefore an interesting approach to control bacterial cell division.

Bacteria with a missing cross-linkage are not able to divide, because they will lysate instead because of the broken peptidoglycane layer. So one possiblity to prevent the crosslinkage is the use of a ß-lactam Antibiotic, like Penicilines, which inhibits the enzyme DD-transpeptidase responsible for the cross-linkage. But another possibility is the prevention of the D-alanine-synthesis in the cell itself, because bacteria without the supply of D-alanine will lyse during cell division.
In E. coli the accumulation of D-alanine can be catalyzed by an alanine racemase (EC 5.1.1.1). This enzyme enables the reversible reaction from L-alanine into the enantiomer D-alanine. For this reaction the cofactor pyridoxal-5'-phosphate (PLP) is also needed as shown in Figure 2. E. coli posses two alanine racemases. One, encoded by alr is constitutively expressed and therefore normally responsible for the accumulation of D-alanine, while the other one encoded by dadX is under control of the dad-operon and usually used in catabolism (Walsh, 1989).

Bild
Figure 2: The alanine racemase Alr from E. coli catalyses the reversible reaction from L-alanine to D-alanine, whereby Pyridoxal-5'-phosphate (PLP) is an essential cofactor for this reaction.

The deletion of the constitutive alanine racemase (alr) and the catabolic alanine racemase (dadX) will lead to a strict dependence of D-alanine, so that the bacteria with these double deletion are only able to grow on media with D-alanine supplementation or by complementation of the alanine racemase on a separate plasmid like BBa_K1465401. This approach can be used for an antibiotic-free selection system and even molecular cloning without antibiotics.

Transformation efficiency

The double deletion of the DH5α and KRX strain, reuslting in the phenotypes KRX Δalr ΔdadX and DH5α Δalr ΔdadX respectivly. This leads to a strict D-alanine auxotrophy, which can be complemented by a plasmid carrying one of the alanine racemases or D-alanine supplementation in the media.
The plasmid BBa_K1465401 used for the complementation carries the konstitutive alanine racemase alr and the chloramphenicol acetyltransferase for the chloramphenicol-resistance (Cm). Besides the plasmid contains RFP BBa_J04450 as a reporter for the characterization of the successful complementation.
For the proof of the antibiotic-free selection the plasmid was transformed in different concentrations into electrocompetent cells of DH5α Δalr ΔdadX. As it turned out, that the cell can store D-alanine for some time the incubation of the cells after the transformation was performed in normal SOC-Media without any supplemntation and in SOC-Media with supplemtation of 3 mM D-alanine to maintian the cell viability of the transformans, before they are able to express the alanine racemase essential for the accumulation of D-alanine and bacterial growth. After the incubation the cells were streaked out either of LB plates for the antibiotica-free selection via complementation of the D-alanine auxotrophy or were streaked out of LB plates containing 30 mg/L Chlormaphenicol as control. The successful transformation could be verified by the red color of the reporter RFP, while false-positive colonies remain white.
An example for the transformation of 0,33 ng of the plasmid BBa_K1465401 into the E. coli strain DH5α Δalr ΔdadX is shown in Figure 3. In the upper row different volumes from 50 µl, 100 µl and 200 µl were plated on LB containing Chloramphenicol and in the lower row the same volumes were streaked out only on normal LB for the selection without any antibiotic. Surprisingly it becomes obvious that the antibiotic-free selection is more efficient than the selection via chloramphenicol, because more colonies could be observed on each plate with an equal volume plated.


Figure 3: Colony forming units (cfu) by the selection of Chloramphenicol (upper row) and antibiotic-free selection (lower row). 0,33 ng of the plasmid BBa_K1465401 were transformed into the E. coli strain DH5α Δalr ΔdadX, incubated in SOC-Media supplemented with 3 mM D-alanine and streaked out in different volumes from 50 µl (left), 100 µl (middle) and 200 µl (right).
In Figure 3 and 4 the colony forming units (cfu) of the transformation of 0,52 ng plasmid BBa_K1465401 after one hour of incubation in either normal SOC-medium or supplemented with 3 mM D-alanine. First of all it can be seen, that the incubation of the transformation is possible also without the supplementation of D-alanine (blue bars), but there are not as much colonies compared to the incubation with 3 mM D-alanine (red bars). Besides the graphics show, that in the absent of D-alanine there are more false-positive phenotypic white colonies (cyan bars) compared to the supplementation of D-alanine (purple bar). In some cases this leads also to huge contaminations so that the amount of false-positive is even higher than the amount of correct colonies. This effect can clearly be seen by streaking out 200 µl of the transformants who were incubated in SOC-Media without D-alanine.
The most interesting aspect turns out by the comparision between the chloramphenicol selection and the antibiotica-free selection (AB-free), because it can be clearly seen, that the amount of positive red colonies is 2,88 +-0,45 (3 mM D-alanine supplemtation) and 5,91 +- 1,53 respectivly (without D-alanine) fold higher compared to the selection with the antibiotic chloramphenicol. This might be due to the active inhibtion of Chlormaphenicol, while the lack of D-alanine can be compensated by intracellular storage of D-alanine or eventually by and temporary grow arrest, until the alanine racemase is expressed.

Figure 4: Colony forming units (cfu) by the selection of Chloramphenicol. 0,52 ng of the plasmid BBa_K1465401 were transformed into the E. coli strain DH5α Δalr ΔdadX and incubated in normal SOC-Media or SOC-Media supplemented with 3 mM D-alanine. After one hour different volumes streaked out on LB containing 30 mg/L Chloramphenicol (n = 2 x 2).

Figure 5: Colony forming units (cfu) by the antibiotic-free selection of LB. 0,52 ng of the plasmid BBa_K1465401 were transformed into the E. coli strain DH5α Δalr ΔdadX and incubated in normal SOC-Media or SOC-Media supplemented with 3 mM D-alanine. After one hour different volumes streaked out on normal LB-Media (n = 2 x 2).
Another important aspect of an antibiotic-free selection approach is the quotient of false-positive and partically the portion of revertants that could also reduce this quotient in a antibiotic-free selection attempt. Therefore the portion of false-positive identified by its white color to the positive red colored transformants are shown in Figure 6. Besides the false-positive transformants in the antibiotic-free selection, there could also be observed false-positive using chloramphenicol selection. This false-positive could be bacteria with a spontane chloramphenicol-resistant, contaminations by bacteria with a Chloramphenicol-resistant or bacteria carrying a mutation within the expression of RFP (BBa_J04450) leading also to a white phenotype. Within the antibiotic-free selection an average portion of 2,83 % +- 0,09 false-positive have been identified, while the antibiotic-selection via chloramphenicol shows only an average of 1,47 % +- 0,77 false-positive. The slightly higher rate of false-positive of the antibiotic-free selection might due to some revertants which are able to accumulate D-alanine also without any alanine racemase by mutation and side reaction of another enzyme, but because of the higher transformation efficiency this effect is actually negligible.

Figure 6: Portion of false-positive colonies of classical antibiotic-selection using chlormaphenicol (red bars) and the antibiotical-free approach (orange bars). The false-positve colonies have been identified by their white phenotype. For the antiobiotic selection an average of 1,47 % +- 0,77 false-positive were estimated, while the portion amount to 2,83 % +- 0,09 for the antibiotic-free selection system.

Transformation process

Räuber Hotzenplotz

Molecular cloning without antibiotics

GFP

Long-term stability of the antiobiotic-free selection

Graphik

Remaining Challenges

MetC Reversion

Summary

References

  • Cava F, Lam H, de Pedro MA, Waldor MK (2011) Emerging knowledge of regulatory roles of d-amino acids in bacteria. Cell and Molecular Life Sciences, vol. 68, pp. 817 - 831.
  • Myhr, Anne and Traavik, Terje (1999) The Precautionary Principle Applied to Deliberate Release of Genetically Modified Organisms (GMOs). Microbial Ecology in Health and Disease, vol. 11, pp. 65 - 74.
  • Walsh, Christopher (1989) Enzymes in the D-alanine branch of bacterial cell wall peptidoglycan assembly. Journal of biological chemistry, vol. 264, pp. 2393 - 2396.
  • Wright O, Stan GB, Ellis T. (2013) Building-in biosafety for synthetic biology. Microbiology, vol. 159, pp. 1221 - 1235.